Who owns the LYMPHIR trademark?

The LYMPHIR trademark is owned by CITIUS ONCOLOGY, INC..

What class is the LYMPHIR trademark registered in?

The LYMPHIR trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LYMPHIR?

The USPTO serial number for LYMPHIR is 97871965.

What is the registration number for LYMPHIR?

LYMPHIR is registered under USPTO registration number 8232731.

Sealvo

Home Search: LYMPHIRLYMPHIR #97871965

Back

Updated Oct 29, 2026·17 searches this week

View on USPTO TSDR Find similar marks

LYM

USPTO Trademark Record

REGISTERED

LYMPHIR

SN 97871965·Reg 8232731·Filed Apr 04, 2023

Owner CITIUS ONCOLOGY, INC.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LYMPHIR (Serial No. 97871965), Registration No. 8232731, is a registered US trademark filed on Apr 04, 2023 by CITIUS ONCOLOGY, INC.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 28, 2032

Mark Intelligence

LYMPHIR (Reg. #8232731) is a registered US trademark that has been protecting its owner, CITIUS ONCOLOGY, INC., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 04, 2023

SERIAL

97871965

REG#

8232731

REGISTERED

Apr 28, 2026

Filing Information

StatusREGISTERED

Filing DateApr 04, 2023

Serial Number97871965

Registration No.8232731

Registration DateApr 28, 2026

Status DateApr 28, 2026

Published for OppositionFeb 06, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 24, 2025

First use in commerce: Nov 24, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

29 events

REGISTERED-PRINCIPAL REGISTER

Apr 28, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 28, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

STATEMENT OF USE PROCESSING COMPLETE

Apr 03, 2026

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 03, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 03, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

TEAS STATEMENT OF USE RECEIVED

Apr 02, 2026

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Apr 02, 2026

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 30, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 29, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Sep 29, 2025

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Sep 29, 2025

SOU EXTENSION 3 GRANTED

SOU EXTENSION 2 GRANTED

Feb 11, 2025

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 11, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 10, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Feb 10, 2025

SOU EXTENSION 2 FILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 20, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 GRANTED

Nov 20, 2024

SOU EXTENSION 1 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 20, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Oct 16, 2024

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

SOU TEAS EXTENSION RECEIVED

Oct 02, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Oct 02, 2024

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 02, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 06, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Feb 06, 2024

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 17, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 31, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Dec 30, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 10, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 07, 2023

NEW APPLICATION ENTERED

Other Marks by CITIUS ONCOLOGY, INC.

Additional USPTO filings from the same owner.

CIT

CITIUS ADVANTAGE

99660544

Citius Oncology, Inc.

PENDING

Other Marks by William S. Fultz

Additional USPTO filings handled by the same attorney of record.

78703788

78703800

SOL KOMFORT

85917015

REGISTERED

LOG

LogoMark

86478708

REGISTERED

LYMPHIR

Run a conflict check

Other Marks by CITIUS ONCOLOGY, INC.

Other Marks by William S. Fultz

Get pre-filing clearance

Search 14M+ trademarks

Industries

USPTO Deadlines

Compare

Resources

Company